A Novel Double-Blind, Placebo-Controlled Food Challenge Matrix for Milk and Raw Egg

被引:8
作者
Vandekerckhove, Marjolein [1 ]
Van Droogenbroeck, Bart [1 ]
De Loose, Marc [1 ]
Coudijzer, Katleen [1 ]
Van Winckel, Myriam [3 ]
Gevaert, Philippe [4 ]
Lapeere, Hilde [2 ]
机构
[1] Res Inst Agr Fisheries & Food, Technol & Food Sci Unit, Burg Van Gansberghelaan 115, BE-9820 Merelbeke, Belgium
[2] Univ Ghent, Fac Med & Hlth Sci, Dept Dermatol, De Pintelaan 185, BE-9000 Ghent, Belgium
[3] Univ Ghent, Fac Med & Hlth Sci, Dept Pediat & Med Genet, Ghent, Belgium
[4] Univ Ghent, Fac Med & Hlth Sci, Dept Otorhinolaryngol, Ghent, Belgium
关键词
Double-blind; placebo-controlled food challenge; Diagnosis of food allergy; Food allergens; Raw egg and milk; INDUCED ENTEROCOLITIS SYNDROME; EUROPEAN ACADEMY; ALLERGY; VALIDATION; IGE; RECIPES;
D O I
10.1159/000494622
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The double-blind, placebo-controlled food challenge (DBPCFC) is still considered to be the gold standard in food allergy diagnosis. This test is however not common practice in routine due to several practical limitations, especially for non-IgE-mediated food allergy with its typical delayed food allergic reactions. Objective: The aim of this study was to develop and evaluate DBPCFC matrices for the diagnosis of milk and egg allergies which can be applied at home for the diagnosis of delayed food allergic reactions. The main focus was the blinding of milk and raw egg and the development of matrices which can be prepared and consumed conveniently at home with a sufficiently long shelf life (+/-6 months or longer). Methods: A sensory test evaluated the blinding of the egg and milk in the matrices. The microbiological analysis confirmed the safety and stability of the developed matrices. To assess the applicability of the matrices, a pilot DBPCFC study for milk including 7 patients was conducted. Results: Sensory tests confirmed that the masking of the allergenic ingredients was sufficient. Microbial safety and stability of the matrices were confirmed up to 6 months of storage at ambient temperatures in the dark. The DBPCFC for milk showed different outcomes and proved its applicability for use at home. Conclusion: A novel stable DBPCFC matrix for milk and raw egg has been developed that allows convenient use at the patients' home. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
[41]   A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy [J].
Skripak, Justin M. ;
Nash, Scott D. ;
Rowley, Hannah ;
Brereton, Nga H. ;
Oh, Susan ;
Hamilton, Robert G. ;
Matsui, Elizabeth C. ;
Burks, A. Wesley ;
Wood, Robert A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (06) :1154-1160
[42]   Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis [J].
Sicherer, SH ;
Morrow, EH ;
Sampson, HA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (03) :582-586
[43]   A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy [J].
Mortz, Charlotte G. ;
Parke, Louise ;
Rasmussen, Helene M. ;
Kjaer, Henrik Fomsgaard ;
Bindslev-Jensen, Carsten .
ALLERGY, 2024, 79 (04) :964-976
[44]   Home-Based Double-Blind, Placebo-Controlled Challenges for Diagnosis of Delayed Gluten/Milk Hypersensitivity in Children [J].
Landaas, Vibeke Ostberg ;
Skjerven, Havard Ove ;
Carlsen, Karin C. Lodrup ;
Stordal, Ketil ;
Haland, Geir .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (03) :652-659.e5
[45]   No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge [J].
Alvarez Garcia, Olaya ;
Bartra, Joan ;
Ruiz-Garcia, Monica ;
Skypala, Isabel J. ;
Durham, Stephen R. ;
Boyle, Robert J. ;
Mills, E. N. Clare ;
Turner, Paul J. .
ALLERGY, 2022, 77 (02) :667-670
[46]   Effects of a probiotic fermented milk on functional constipation: A randomized, double-blind, placebo-controlled study [J].
Mazlyn, Mena Mustapha ;
Nagarajah, Lee Hun-Leong ;
Fatimah, Arshad ;
Norimah, A. Karim ;
Goh, Khean-Lee .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (07) :1141-1147
[47]   Desmopressin in the treatment of nocturia:: A double-blind, placebo-controlled study [J].
van Kerrebroevk, Philip ;
Rezapour, Masoumeh ;
Cortesse, Ariane ;
Thueroff, Joachim ;
Riis, Anders ;
Norgaard, Jens Peter .
EUROPEAN UROLOGY, 2007, 52 (01) :221-229
[48]   Sublingual immunotherapy for hazelnut food allergy:: A randomized, double-blind, placebo-controlled study with a standardized hazelnut extract [J].
Enrique, E ;
Pineda, F ;
Malek, T ;
Bartra, J ;
Basagaña, M ;
Tella, R ;
Castelló, JV ;
Alonso, R ;
de Mateo, JA ;
Cerdá-Trias, T ;
Miguel-Moncín, MDM ;
Monzón, S ;
García, M ;
Palacios, R ;
Cisteró-Bahíma, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) :1073-1079
[49]   Differences between observers in interpreting double-blind placebo-controlled food challenges: A randomized trial [J].
Brand, Paul L. P. ;
Landzaat-Berghuizen, Marlouk A. .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2014, 25 (08) :755-759
[50]   A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy [J].
Wood, Robert A. ;
Kim, Jennifer S. ;
Lindblad, Robert ;
Nadeau, Kari ;
Henning, Alice K. ;
Dawson, Peter ;
Plaut, Marshall ;
Sampson, Hugh A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (04) :1103-+